ADVB
Advanced Biomed Inc.
Company overview
- Market capitalization
- $9.30M
- Employees
- 31
- Latest publication
- 2026-09-29
About Advanced Biomed Inc.
Advanced Biomed Inc., an investment holding company, engages in the research and development of microfluidic biochip technologies for precision oncology detection, diagnosis, and treatment in Taiwan. Its devices include A+Pre, an automated sample preparation system that enables pre-concentration of diluted blood samples; AC-1000, a rare cell device to solve the problem of detection of hypercoagulable state samples of tumor patients; A+SCDrop, a circulating tumor cell (CTC) single-cell capture device; and A+CellScan, an analyzer with an immunostaining chip for immunostaining/analysis of the AC-1000 product. The company also offers microfluidic biochips, such as A+Pre, AC-1000 CTC enrichment, and A+CellScan chips to provide assay products and services to cancer patients. In addition, its immunochromogenic kits include A+CTCE kit to identify epithelial circulating tumor cells and determined by the immunochromogenicity of EpCAM, CK (pan), CD45, and CD14 antibodies; A+CTCM kit to identify mesenchymal circulating tumor cells based on the immunochromogenicity of Vimentin, CD45, and CD14 antibodies; A+EMT to identify epithelial-to-mesenchymal circulating tumor cells determined by the immunochromogenicity of cell-surface Vimentin, and CD45 and CD14 antibodies; and A+CM to identify tumor-associated macrophages based on the immunochromogenicity of PD-L1, CD45, and CD14 antibodies. Further, the company is developing A+LCGuard for early screening of lung cancer. Additionally, it establishes and operates medical clinics in the People's Republic of China. The company was founded in 2014 and is headquartered in New York, New York.
Financial statements
Income Quarterly
| Metric | Q3 20262026-03-31 · USD | Q2 20262025-12-31 · USD | Q1 20262025-09-30 · USD | Q3 20252025-03-31 · USD | Q2 20252024-12-31 · USD | Q1 20252024-09-30 · USD | Q4 20242024-06-30 · USD | Q3 20242024-03-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 0USD | 0USD | 17,200USD | 0USD | 0USD | 0USD | 0USD | 0USD |
| Cost Of Revenue | 295USD | 466USD | 2,085USD | 680USD | — | 3,162USD | — | 2,375USD |
| Gross Profit | -294USD | -466USD | -2,085USD | -680USD | — | -3,162USD | — | -2,375USD |
| Research Development | 243,226USD | 6,003USD | 235,992USD | 250,462USD | 212,397USD | 181,703USD | 209,112USD | 313,509USD |
| Selling General Administrative | 276,610USD | 210,311USD | 260,603USD | 438,769USD | 67,667USD | 311,032USD | 177,008USD | 404,738USD |
| Total Operating Expenses | 519,836USD | 12,313USD | 523,914USD | 762,739USD | 280,064USD | 520,027USD | 704,613USD | 745,412USD |
| Operating Income | -519,836USD | -12,778USD | -523,914USD | -762,739USD | -280,064USD | -520,027USD | -704,613USD | -745,412USD |
| Interest Expense | 112USD | — | — | — | — | — | — | — |
| Net Interest Income | -112USD | 9,206USD | 448USD | 0USD | 15,377USD | 10USD | 33,411USD | 104USD |
| Income Before Tax | -488,942USD | 225,595USD | -386,901USD | -1,383,874USD | -579,494USD | -265,580USD | -809,386USD | -1,056,231USD |
| Tax Provision | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD |
| Net Income | -488,942USD | 220,947USD | -386,901USD | -1,383,874USD | -907,904USD | -265,580USD | -809,386USD | -1,056,231USD |
| Net Income From Continuing Ops | -488,942USD | 7,002,178USD | -386,901USD | -1,383,874USD | -579,494USD | -265,580USD | -809,386USD | -1,056,231USD |
| Ebit | -488,830USD | -12,778USD | -523,914USD | -762,739USD | — | -520,027USD | -704,613USD | -745,412USD |
| Ebitda | -479,504USD | -12,312USD | -475,922USD | -528,769USD | — | -417,809USD | -386,120USD | -662,396USD |
| Depreciation And Amortization | 9,326USD | 466USD | 47,992USD | 233,970USD | — | 102,218USD | 318,493USD | 83,016USD |
| Reconciled Depreciation | 9,326USD | -12,857USD | 47,992USD | 78,139USD | -56,760USD | 102,218USD | 153,911USD | 83,016USD |
| Total Other Income Expense Net | 30,894USD | 238,373USD | 137,013USD | -621,135USD | -314,807USD | 254,447USD | -104,773USD | -310,819USD |
| Interest Income | — | 9,206USD | 448USD | 0USD | 15,377USD | 10USD | 33,411USD | 104USD |
| Income Tax Expense | — | 144,257USD | — | — | — | — | — | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Income Yearly
| Metric | FY 20252025-06-30 · USD | FY 20242024-06-30 · USD | FY 20232023-06-30 · USD | FY 20222022-06-30 · USD | FY 20212021-06-30 · USD |
|---|---|---|---|---|---|
| Cost Of Revenue | 10,711USD | 12,550USD | 11,890USD | 4,477USD | 2,031USD |
| Gross Profit | -10,711USD | -12,550USD | -11,890USD | -4,477USD | -2,031USD |
| Research Development | 28,341USD | 880,193USD | 45,029USD | 1,619,531USD | 1,734,620USD |
| Selling General Administrative | 2,111,265USD | 1,261,777USD | 1,322,811USD | 624,774USD | 44,470USD |
| Unclassified Operating Expenses | -2,056,205USD | — | -1,279,746USD | — | — |
| Total Operating Expenses | 83,401USD | 2,541,572USD | 88,094USD | 2,374,371USD | 1,836,940USD |
| Operating Income | -94,112USD | -2,541,572USD | -99,984USD | -2,374,371USD | -1,836,940USD |
| Income Before Tax | -101,524USD | -2,782,278USD | -121,521USD | -4,027,722USD | -1,837,158USD |
| Net Income | -101,524USD | -2,782,278USD | -121,521USD | -4,027,722USD | -1,837,158USD |
| Ebit | -94,112USD | -2,541,572USD | -99,984USD | -2,374,371USD | -1,836,940USD |
| Ebitda | -83,401USD | -2,141,970USD | -88,094USD | -2,244,305USD | -1,779,090USD |
| Depreciation And Amortization | 10,711USD | 399,602USD | 11,890USD | 130,066USD | 57,850USD |
| Total Other Income Expense Net | -7,412USD | -240,706USD | -21,537USD | -1,653,351USD | -218USD |
| Total Revenue | — | 0USD | 0USD | 0USD | 0USD |
| Interest Income | — | 53,495USD | 21,402USD | 243USD | 28USD |
| Net Interest Income | — | 53,495USD | 21,402USD | 243USD | 28USD |
| Tax Provision | — | 0USD | 0USD | 0USD | 0USD |
| Net Income From Continuing Ops | — | -2,782,278USD | -3,732,777USD | -4,027,722USD | -1,837,158USD |
| Reconciled Depreciation | — | 399,602USD | 365,231USD | 126,632USD | 57,850USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Quarterly
| Metric | Q3 20262026-03-31 · USD | Q2 20262025-12-31 · USD | Q1 20262025-09-30 · USD | Q4 20252025-06-30 · USD | Q3 20252025-03-31 · USD | Q2 20252024-12-31 · USD | Q1 20252024-09-30 · USD | Q4 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 333,009USD | 345,338USD | 204,835USD | — | 8,287,598USD | 4,504,152USD | 4,473,771USD | 4,460,247USD |
| Other Current Assets | 244,823USD | 256,091USD | 94,544USD | — | 7,568,539USD | — | 477,815USD | 443,137USD |
| Total Liab | 44,935USD | 43,572USD | 106,268USD | — | 4,157,815USD | 3,885,120USD | 3,379,941USD | 2,796,989USD |
| Total Stockholder Equity | 288,074USD | 301,766USD | 98,566USD | — | 4,129,783USD | 619,032USD | 1,093,830USD | 1,663,258USD |
| Other Current Liab | 9,930USD | 9,239USD | 29,379USD | — | -4,167USD | — | 1,413,973USD | 2,047,856USD |
| Common Stock | 43USD | 689USD | 710USD | — | 21,640USD | — | 20,000USD | 20,000USD |
| Capital Stock | 1,382USD | 21,640USD | 21,640USD | — | 21,640USD | 20,000USD | 20,000USD | 20,000USD |
| Retained Earnings | -414,481USD | -406,168USD | -643,741USD | — | -18,531,433USD | -17,147,559USD | -16,239,655USD | -15,974,074USD |
| Other Assets | 0USD | 0USD | — | — | — | — | — | — |
| Cash | 81,410USD | 82,897USD | 87,161USD | — | 156,135USD | 2,657,235USD | 2,646,992USD | 2,607,973USD |
| Cash And Short Term Investments | 81,410USD | 82,897USD | 87,161USD | — | 156,135USD | — | 2,646,992USD | 2,607,973USD |
| Total Current Assets | 329,255USD | 341,546USD | 191,749USD | — | 7,731,148USD | 3,138,891USD | 3,132,736USD | 3,051,110USD |
| Total Current Liabilities | 44,594USD | 39,896USD | 99,906USD | — | 4,113,343USD | 3,828,794USD | 3,309,372USD | 2,732,460USD |
| Net Debt | -58,206USD | -60,317USD | -31,322USD | — | 30,861USD | — | -1,322,979USD | -2,479,316USD |
| Short Term Debt | 22,863USD | 18,904USD | 49,477USD | — | 142,524USD | — | 1,253,444USD | 64,128USD |
| Short Long Term Debt Total | 23,204USD | 22,580USD | 55,839USD | — | 186,996USD | — | 1,324,013USD | 128,657USD |
| Net Receivables | 3,021USD | 2,558USD | 10,044USD | — | 6,474USD | — | 7,929USD | 6,324USD |
| Inventory | 8,835USD | 9,069USD | 9,296USD | — | -7,805USD | — | — | -6,324USD |
| Accounts Payable | 11,800USD | 11,753USD | 21,050USD | — | 3,974,986USD | 617,865USD | 641,955USD | 620,476USD |
| Property Plant Equipment Net | 3,685USD | 3,762USD | 10,632USD | — | 180,851USD | 642,274USD | 601,294USD | 651,269USD |
| Property Plant Equipment Gross | 1,079,585USD | 1,091,621USD | 1,894,721USD | — | 1,925,978USD | 1,993,424USD | 1,935,700USD | 1,881,726USD |
| Accumulated Other Comprehensive Income | 26,393USD | 27,840USD | 41,182USD | — | 1,292,298USD | — | 819,496USD | 1,123,344USD |
| Common Stock Shares Outstanding | 1,284,923shares | 1,082,000shares | 1,082,000shares | 1,082,000shares | 20,479,101shares | 1,082,000shares | 21,640,000shares | 1,000,000shares |
| Non Current Assets Total | 3,753USD | 3,792USD | 13,086USD | — | 556,450USD | 1,365,261USD | 1,341,035USD | 1,409,137USD |
| Non Current Liabilities Total | 341USD | 3,676USD | 6,362USD | — | 44,472USD | 56,326USD | 70,569USD | 64,529USD |
| Non Currrent Assets Other | 68USD | 30USD | 2,454USD | — | 355,274USD | — | 655,671USD | 638,870USD |
| Net Working Capital | 9,100,625USD | 9,477,991USD | 2,799,181USD | — | 3,617,805USD | -689,903USD | -176,636USD | 318,650USD |
| Intangible Assets | — | — | — | — | 20,325USD | 50,516USD | 84,070USD | 118,998USD |
| Unclassified Equity | — | — | — | — | 21,325,638USD | 17,746,591USD | 16,473,989USD | 16,473,988USD |
| Unclassified Current Liabilities | — | — | — | — | — | 3,210,929USD | — | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Yearly
| Metric | FY 20252025-06-30 · USD | FY 20242024-06-30 · USD | FY 20232023-06-30 · USD | FY 20222022-06-30 · USD | FY 20212021-06-30 · USD |
|---|---|---|---|---|---|
| Total Assets | 6,512,343USD | 4,460,247USD | 4,599,977USD | 6,713,499USD | 1,006,373USD |
| Other Current Assets | 3,128,648,044USD | 443,137USD | 158,895USD | 221,847USD | 847,156USD |
| Total Liab | 3,034,779USD | 2,796,989USD | 3,294,389USD | 3,221,903USD | 30,131USD |
| Total Stockholder Equity | 3,477,564USD | 1,663,258USD | 1,305,588USD | 3,491,596USD | 976,242USD |
| Other Current Liab | 2,887,987,164USD | 2,047,856USD | 2,419,243USD | 1,982,874USD | 22,727USD |
| Common Stock | 21,640USD | 20,000USD | 20,000USD | 99,000USD | 14,721USD |
| Retained Earnings | -19,233,044USD | -15,974,074USD | -13,191,797USD | -9,459,020USD | -5,431,298USD |
| Cash | 2,903,915USD | 2,607,973USD | 2,622,279USD | 4,783,864USD | 65,922USD |
| Cash And Short Term Investments | 2,903,915USD | 2,607,973USD | 2,622,279USD | 4,783,864USD | 65,922USD |
| Total Current Assets | 6,032,571USD | 3,051,110USD | 2,785,988USD | 5,005,711USD | 913,497USD |
| Total Current Liabilities | 2,889,128USD | 2,732,460USD | 3,275,583USD | 2,989,712USD | 28,350USD |
| Net Debt | -2,902,650,171USD | -2,479,316USD | -2,379,953USD | -4,307,037USD | -58,713USD |
| Short Term Debt | 1,119,178USD | 64,128USD | 223,520USD | 244,636USD | 5,428USD |
| Short Long Term Debt Total | 1,264,829USD | 128,657USD | 242,326USD | 476,827USD | 7,209USD |
| Net Receivables | 7,956USD | 6,324USD | 4,814USD | 162,518USD | 419USD |
| Accounts Payable | 21,658USD | 620,476USD | 632,820USD | 762,202USD | 194USD |
| Property Plant Equipment Net | 65,399,000USD | 651,269USD | 954,070USD | 1,225,968USD | 92,876USD |
| Accumulated Other Comprehensive Income | 1,341,690USD | 1,123,344USD | 804,020USD | 268,859USD | -177,086USD |
| Common Stock Shares Outstanding | 1,082,000shares | 1,082,000shares | 1,082,000shares | 1,082,000shares | 21,640,000shares |
| Non Current Assets Total | 479,772USD | 1,409,137USD | 1,813,989USD | 1,707,788USD | 92,876USD |
| Non Current Liabilities Total | 145,651USD | 64,529USD | 18,806USD | 232,191USD | 1,781USD |
| Non Currrent Assets Other | 414,373USD | 638,870USD | 609,598USD | 71,021USD | — |
| Unclassified Current Assets | -3,125,527,344USD | — | — | — | — |
| Unclassified Non Current Assets | -65,333,601USD | — | — | — | — |
| Unclassified Current Liabilities | -2,886,238,872USD | — | — | — | — |
| Unclassified Equity | 21,347,278USD | 16,473,988USD | 13,653,365USD | 12,483,757USD | 6,555,184USD |
| Intangible Assets | — | 118,998USD | 250,321USD | 410,799USD | — |
| Capital Stock | — | 20,000USD | 20,000USD | 99,000USD | 14,721USD |
| Inventory | — | -6,324USD | — | — | — |
| Property Plant Equipment Gross | — | 1,881,726USD | 1,950,441USD | 2,031,592USD | 842,664USD |
| Net Working Capital | — | 318,650USD | -489,595USD | 2,015,999USD | 885,147USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Quarterly
| Metric | Q3 20262026-03-31 · USD | Q2 20262025-12-31 · USD | Q1 20262025-09-30 · USD | Q3 20252025-03-31 · USD | Q2 20252024-12-31 · USD | Q1 20252024-09-30 · USD | Q4 20242024-06-30 · USD | Q3 20242024-03-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -15,455USD | 225,595USD | -386,901USD | -42,075USD | -907,904USD | -265,580USD | -809,386USD | -932,808USD |
| Depreciation | 295USD | 466USD | 47,992USD | 2,375USD | -56,760USD | 102,218USD | 153,911USD | 118,464USD |
| Other Non Cash Items | 888USD | -261,602USD | 327,589USD | -3,305,847USD | -15,417USD | -10USD | 345,723USD | -241,338USD |
| Change In Working Capital | 7,376USD | 19,731USD | -9,070USD | -64,025USD | -88,709USD | 133,682USD | 179,647USD | -9,976USD |
| Total Cash From Operating Activities | -6,895USD | -15,811USD | -20,390USD | -3,409,572USD | -841,841USD | -29,680USD | -475,828USD | -1,065,658USD |
| Capital Expenditures | -35USD | -419USD | -59USD | -2,215USD | 0USD | -19,978USD | -53,256USD | -26,699USD |
| Free Cash Flow | -6,930USD | -16,230USD | -20,450USD | -3,411,787USD | -831,149USD | -49,658USD | -529,084USD | -1,038,959USD |
| Total Cashflows From Investing Activities | -31USD | -413USD | -59USD | -2,215USD | — | -19,978USD | -53,256USD | 26,699USD |
| Total Cash From Financing Activities | 8,015USD | 9,625USD | 14,949USD | 5,898,956USD | 78,327USD | 392,525USD | 323,536USD | 562,199USD |
| Change In Cash | -1,487USD | -4,264USD | -12,247USD | 2,526,865USD | 10,243USD | 39,019USD | -55,731USD | -112,918USD |
| Begin Period Cash Flow | 82,897USD | 87,161USD | 99,408USD | 2,657,235USD | 2,646,992USD | 2,607,973USD | 2,663,704USD | 2,776,622USD |
| End Period Cash Flow | 81,410USD | 82,897USD | 87,161USD | 5,184,100USD | 2,647,656USD | 2,646,992USD | 2,607,973USD | 2,663,704USD |
| Other Cashflows From Financing Activities | -390USD | 20,675USD | -33,363USD | 5,727,583USD | — | 393,044USD | 323,536USD | 562,199USD |
| Investments | — | — | -1,771USD | -2,215USD | 10,692USD | -19,978USD | -53,256USD | 26,699USD |
| Other Cashflows From Investing Activities | — | — | -1,771USD | -2,152USD | — | — | -39,978USD | 39,977USD |
| Change To Account Receivables | — | — | — | — | — | 10USD | — | — |
| Issuance Of Capital Stock | — | — | — | — | — | — | 0USD | 0USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Yearly
| Metric | FY 20252025-06-30 · USD | FY 20242024-06-30 · USD | FY 20232023-06-30 · USD | FY 20222022-06-30 · USD | FY 20212021-06-30 · USD |
|---|---|---|---|---|---|
| Net Income | -101,524USD | -2,782,278USD | -3,732,777USD | -4,027,722USD | -1,837,158USD |
| Depreciation | 10,711USD | 399,602USD | 365,231USD | 126,632USD | 57,850USD |
| Other Non Cash Items | 2,915,048,186USD | -53,495USD | 150,207USD | 1,655,608USD | -28USD |
| Change In Working Capital | -90,650USD | 256,336USD | 253,714USD | 1,504,032USD | 1,305,333USD |
| Total Cash From Operating Activities | -181,464USD | -2,126,340USD | -2,963,625USD | -741,450USD | -473,975USD |
| Capital Expenditures | -985USD | -74,110USD | -212,523USD | -1,312,130USD | -25,442USD |
| Free Cash Flow | -182,450USD | -2,200,450USD | -3,176,148USD | -2,053,580USD | -499,417USD |
| Total Cashflows From Investing Activities | -985USD | -74,110USD | -263,009USD | -1,083,684USD | -25,442USD |
| Total Cash From Financing Activities | 184,867USD | 1,866,820USD | 458,137USD | 6,097,131USD | 697,164USD |
| Change In Cash | 19,018USD | -14,306USD | -2,161,585USD | 4,717,942USD | 217USD |
| Begin Period Cash Flow | 80,390USD | 2,622,279USD | 4,783,864USD | 65,922USD | 65,705USD |
| End Period Cash Flow | 99,408USD | 2,607,973USD | 2,622,279USD | 4,783,864USD | 65,922USD |
| Unclassified Operating Cash Flow | -2,915,048,187USD | — | — | — | — |
| Change To Account Receivables | — | 53,495USD | 21,402USD | 243USD | 28USD |
| Investments | — | -74,110USD | -263,009USD | -1,083,684USD | -25,442USD |
| Net Borrowings | — | 1,657,320USD | 0USD | — | — |
| Issuance Of Capital Stock | — | 0USD | 1,011,608USD | 6,097,131USD | 697,164USD |
| Other Cashflows From Financing Activities | — | 212,182USD | -553,471USD | — | — |
| Other Cashflows From Investing Activities | — | — | -1,640USD | -393,617USD | — |
| Unclassified Investing Cash Flow | — | — | — | 1,705,747USD | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Operating metrics
No operating metrics are currently published for this company.
Revenue breakdown
No revenue breakdown is currently published for this company.
Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.